Stay updated with breaking news from Uzi Sofer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
September 27, 2023 Dear Alpha Tau Medical Ltd. Shareholders: We cordially invite you to attend the annual general meeting of shareholders of Alpha Tau Medical...
- 81 lesions treated across four feasibility trials of head and neck or skin cancers demonstrated 89% complete response rate.
-First patient treated in the feasibility and safety study of intratumoral diffusing alpha-emitters radiation therapy for the treatment of new and recurrent squamous cell carcinoma of the... | May 17, 2023
First patient treated in the feasibility and safety study of intratumoral diffusing alpha radiation emitters for the treatment of advanced inoperable pancreatic cancer. JERUSALEM, April 03,... | April 3, 2023
First patient treated in the feasibility and safety study of intratumoral diffusing alpha radiation emitters for the treatment of advanced inoperable...